Kathleen D Ullmer

Title: Kathleen D Ullmer: Innovator in Pharmaceutical Formulations

Introduction

Kathleen D Ullmer is a notable inventor based in San Mateo, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. Her work focuses on enhancing the efficacy and delivery of hormone-related medications.

Latest Patents

Kathleen D Ullmer holds a patent for "Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists." This patent includes combination solid oral dosage forms containing 40 mg of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea, or a corresponding amount of a pharmaceutically acceptable salt thereof, along with hormone replacement medicaments. The patent also outlines processes for making and using these solid oral dosage forms.

Career Highlights

Kathleen is associated with Sumitomo Pharma Co., Ltd., where she has been instrumental in advancing pharmaceutical research and development. Her innovative approach has led to the creation of effective medication formulations that address critical health needs.

Collaborations

Throughout her career, Kathleen has collaborated with esteemed colleagues, including David E Alonzo and Minli Xie. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Kathleen D Ullmer's contributions to pharmaceutical innovations exemplify her dedication to improving healthcare through effective medication delivery systems. Her work continues to influence the field and inspire future advancements in pharmaceutical formulations.